[DOI] [PMC free article] [PubMed] [Google Scholar] Adams GE, Armstrong RC, Charlesby A, et al
According to a recent report by Allied Market Research, the global oral polypeptide drugs market is projected to grow from USD 643 million in 2016 to USD 8.23 billion in 2028, displaying tremendous market demand and business value
Health Canada typically reviews obesity medications on timelines of 1-2 years following FDA approval in the United States
Excitotoxicity was one of the first mechanisms of neuronal damage that was identified
A plateau simply means the body has reached a new balance
In one study, it was demonstrated that exendin-4 prevented LPS-induced depressive-like symptoms in rats and displayed antidepressant-like properties measured in the forced swim test, but this effect was not mediated by the modulation of neuroinflammatory processes, since the levels of IL-1 and TNF- were not affected by exendin-4 treatment [67]